Fidelity Investments
LBRX

Fidelity Investments’s LB Pharmaceuticals LBRX Stock Holding History

Fidelity Investments’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.13M Sell
188,907
-33,601
-15% -$987K ﹤0.01% 2344
2026
Q1 		$5.49M Buy
222,508
+643
+0.3% +$14.8K ﹤0.01% 2274
2025
Q4 		$4.94M Sell
221,865
-147,235
-40% -$2.57M ﹤0.01% 2292
2025
Q3 		$5.83M Buy
+369,100
New +$5.86M ﹤0.01% 2191

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Fidelity Investments's LBRX Position: Q2 2026 in Review

Fidelity Investments reduced its LB Pharmaceuticals (LBRX) stake by 15% in Q2 2026, selling an estimated $987K and leaving 188,907 shares worth $6.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

Fidelity Investments first reported a position in LBRX in Q3 2025 and has held it in 4 quarters since. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • Fidelity Investments held 188,907 shares of LB Pharmaceuticals worth $6.13M as of Q2 2026.
  • Fidelity Investments sold 33,601 LB Pharmaceuticals shares in Q2 2026, an estimated $987K.
  • LB Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2344 holding.
  • Fidelity Investments first reported a position in LB Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.